MetLife (NYSE:MET – Free Report) had its price objective hoisted by Morgan Stanley from $80.00 to $82.00 in a report published on Monday, Benzinga reports. They currently have an overweight rating on the financial services provider’s stock. A number of other research analysts have also recently weighed in on the stock. UBS Group dropped their […]